Roche Holding stock: sales update due October 22, 2026 pre-market
Published on 10/20/2026 at 08:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming company event
- Roche’s third-quarter sales update is scheduled for October 22, 2026.
- The investor calendar also lists a conference on November 2, 2026.
- Roche Holding stock trades pre-market at EUR 410.88 at 7:58 a.m. CEST at Lang & Schwarz on October 20, 2026.
Roche Holding’s investor calendar lists its third-quarter sales update for October 22, 2026, according to the company’s investor-relations page. Roche Holding stock trades pre-market at EUR 410.88 at 7:58 a.m. CEST at Lang & Schwarz on October 20, 2026.
Upcoming sales update
The company’s calendar identifies the October 22 event as “Roche 3rd Quarter Sales 2026,” a virtual event scheduled for 2:00 p.m. CEST in Basel, Switzerland. The calendar also lists a Berenberg Pharma CFO Series event for November 2, 2026, at 3:00 p.m. CET.
Ahead of the Xetra open
The pre-market indication was recorded at 7:58 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Roche Holding stock.
Pharmaceuticals and diagnostics
Roche operates pharmaceutical and diagnostics businesses. The October 22 sales update is the next company event listed on its investor calendar, while the next listed investor event is scheduled for November 2, 2026.
Market context: Market report SMI.
